| Common Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
13,923,611 |
shares |
|
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Valuation Allowance |
$437,411 |
USD |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Gross |
$437,411 |
USD |
|
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability |
$53,357 |
USD |
|
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$54,978 |
USD |
|
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability, Current |
$32,489 |
USD |
|
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$38,634 |
USD |
|
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$16,344 |
USD |
|
Q3 2025 |
Q2 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0363 |
pure |
0% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$1,621 |
USD |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$348,658 |
USD |
|
Q3 2025 |
Q2 2026 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q3 2025 |
Q2 2026 |
| Additional Paid in Capital |
$15,716,444 |
USD |
|
Q3 2025 |
Q2 2026 |